Skip to content

Healthy, Immunized Communities Study

A Randomized Study to Determine the Efficacy of a Multi-tiered Community- and School-based Approach to Enhance School-aged Children's Recommended Vaccinations.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03854734
Enrollment
148
Registered
2019-02-26
Start date
2019-02-14
Completion date
2023-02-09
Last updated
2024-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaccine Hesitancy, Communicable Diseases in Children

Keywords

Vaccinations, Vaccine hesitancy, School-based research

Brief summary

This project aims to understand how improving vaccine education and awareness can impact the number of parents who vaccinate, or intend to vaccine, their middle school-aged children with age-appropriate vaccines, including human papillomavirus (HPV), meningitis (MCV) and tetanus, diphtheria, pertussis (TDap).

Detailed description

Vaccines are considered one of the greatest public health successes. Unfortunately, an increasing rate of parental resistance in recent years has led to a reemergence of vaccine-preventable diseases. This project seeks to determine the effect of a multi-tiered school and community-based approach to improving rates of parental intent to vaccinate for middle school-aged vaccinations including Human Papillomavirus (HPV), meningitis (MCV) and Tetanus, Diphtheria, Pertussis (TDap). By randomizing participating schools, parents receiving the intervention participated in (1) a community-based event to raise parental awareness of the importance of vaccination and (2) a social marketing campaign targeting parents' attitudes and knowledge around vaccinations. The Investigators hypothesized that participation in this study would increase parental intention to vaccinate. In addition, this study intended to improve rates of recommended vaccination among middle school-aged children, as measured through vaccine uptake information required for annual entry into Pennsylvania public schools. The Penn State team brings a breadth of experience in pediatrics, community-engaged research, adolescent health, and engagement with schools.

Interventions

BEHAVIORALCommunity Event

Formative focus group data was used to design an educational community event to improve information share and vaccine education/knowledge.

Formative focus group data was used to design educational messaging to be electronically distributed to intervention participants

Sponsors

Merck Sharp & Dohme LLC
CollaboratorINDUSTRY
Milton S. Hershey Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Investigator)

Masking description

Following collection of baseline data, schools will be randomized. Study staff measuring the primary outcome will be blinded to school group assignment. Given the intervention, it is not possible to blind participants to group assignment.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older * Parents and guardians of children who attend a School District of Lancaster middle schools * Individuals who read and understand English * Individuals with an email address

Exclusion criteria

* Individuals who are non-English speaking * Parents/Guardians \<18 years or older who do not have children attending a middle school in the School District of Lancaster * Individuals who do not have an email address * Individuals who plan on moving out of the Lancaster City area in the next year

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV)Participants were assessed at baseline and follow-up at 6 months.Parental intent to vaccinate their adolescent child with Tdap, MCV, and HPV vaccines, was dichotomized for each vaccine in the survey. Tdap and MCV included the options 1) intention to vaccinate/vaccinated (plan to get this shot before the first day of 7th grade or up-to-date with this shot) or 2) no intention to vaccinate (no plans to get this shot or have or plan to submit an exemption for this shot). The HPV variable excluded the option have or plan to submit an exemption for this shot as vaccine is not required for school entry. Variables (Tdap, MCV, HPV) were compared within and between treatment groups from baseline to 6 mo. follow up with a generalized estimating equations model using the framework of a log-binomial logistic regression model. Risk ratios resulting from these models were used to quantify the magnitude and direction of any significant differences.

Countries

United States

Participant flow

Recruitment details

Recruitment occurred between February and September 2019. Participants were recruited through the participating school partner, who distributed a recruitment flyer via email and through social media channels. Participants were also recruited through in-person events at the participating schools, such as chorus concerts and parent-teacher conferences.

Pre-assignment details

Four schools were randomized to two arms (intervention vs. control). 502 individuals were assessed for eligibility and 354 were excluded for not meeting inclusion criteria (n=265) or declining to participate (n=89).

Participants by arm

ArmCount
Usual Care
Educational emails about broad health topics to keep control group engaged
70
Multi-Component Intervention
(1) a community event to raise parental awareness of the importance of vaccination; (2) social marketing to target parents' attitudes and knowledge around vaccinations in the form of educational material Community Event: Formative focus group data was used to design an educational community event to improve information share and vaccine education/knowledge. Educational Material: Formative focus group data was used to design educational messaging to be electronically distributed to intervention participants
78
Total148

Baseline characteristics

CharacteristicUsual CareMulti-Component InterventionTotal
Age, Continuous38.00 years
STANDARD_DEVIATION 9.79
40.46 years
STANDARD_DEVIATION 8.59
39.32 years
STANDARD_DEVIATION 9.21
Annual household income
≤$40,000
31 Participants27 Participants58 Participants
Annual household income
$40,001 - $80,000
26 Participants25 Participants51 Participants
Annual household income
>$80,000
12 Participants23 Participants35 Participants
Annual household income
No Response
1 Participants3 Participants4 Participants
Education
College Graduate
20 Participants37 Participants57 Participants
Education
High School or Less
35 Participants29 Participants64 Participants
Education
No response
0 Participants0 Participants0 Participants
Education
Some College
15 Participants12 Participants27 Participants
Gender of child
Female
30 Participants34 Participants64 Participants
Gender of child
Male
40 Participants44 Participants84 Participants
Grade of child
6th
37 Participants33 Participants70 Participants
Grade of child
7th
22 Participants29 Participants51 Participants
Grade of child
8th
11 Participants16 Participants27 Participants
Parent participation in school events per year
≤1
41 Participants37 Participants78 Participants
Parent participation in school events per year
2-5
25 Participants24 Participants49 Participants
Parent participation in school events per year
≥6
4 Participants16 Participants20 Participants
Parent participation in school events per year
No response
0 Participants1 Participants1 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Black/African American
6 Participants7 Participants13 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Hispanic or Latino
22 Participants20 Participants42 Participants
Race/Ethnicity, Customized
Race/Ethnicity
No response
0 Participants1 Participants1 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Other
10 Participants7 Participants17 Participants
Race/Ethnicity, Customized
Race/Ethnicity
White
32 Participants43 Participants75 Participants
Relationship Status
Married OR living with partner
43 Participants46 Participants89 Participants
Relationship Status
No response
1 Participants2 Participants3 Participants
Relationship Status
Single OR separated OR divorced OR widowed
26 Participants30 Participants56 Participants
Relationship to child
Father
9 Participants8 Participants17 Participants
Relationship to child
Guardian/Grandparent
5 Participants4 Participants9 Participants
Relationship to child
Mother
56 Participants66 Participants122 Participants
Sex/Gender, Customized
Gender
Female
57 Participants68 Participants125 Participants
Sex/Gender, Customized
Gender
Male
11 Participants7 Participants18 Participants
Sex/Gender, Customized
Gender
No response
2 Participants3 Participants5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Percentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV)

Parental intent to vaccinate their adolescent child with Tdap, MCV, and HPV vaccines, was dichotomized for each vaccine in the survey. Tdap and MCV included the options 1) intention to vaccinate/vaccinated (plan to get this shot before the first day of 7th grade or up-to-date with this shot) or 2) no intention to vaccinate (no plans to get this shot or have or plan to submit an exemption for this shot). The HPV variable excluded the option have or plan to submit an exemption for this shot as vaccine is not required for school entry. Variables (Tdap, MCV, HPV) were compared within and between treatment groups from baseline to 6 mo. follow up with a generalized estimating equations model using the framework of a log-binomial logistic regression model. Risk ratios resulting from these models were used to quantify the magnitude and direction of any significant differences.

Time frame: Participants were assessed at baseline and follow-up at 6 months.

Population: 4 middle schools were randomized to either a usual care or multi-component intervention arm. Participants (parents) were assigned to a study arm based on their associated middle school. 30 participants either did not complete the follow up survey (n=27) or did not answer all questions (n=3), as questions were not required. Discrepancies in percentage reporting in the outcomes table below results from inconsistent rates of missingess (range 0-4) across variables (Tdap, MCV, HPV).

ArmMeasureGroupValue (NUMBER)
Usual CarePercentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV)Tetanus, diphtheria, acellular pertussis (Tdap) : Vaccine intention at baseline74.3 percentage of participants
Usual CarePercentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV)Tetanus, diphtheria, acellular pertussis (Tdap) : Vaccine intention at follow-up97.9 percentage of participants
Usual CarePercentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV)Meningococcal conjugate vaccine (MCV) : Vaccine intention at baseline72.9 percentage of participants
Usual CarePercentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV)Meningococcal conjugate vaccine (MCV) : Vaccine intention at follow-up91.5 percentage of participants
Usual CarePercentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV)Human papillomavirus (HPV) : Vaccine intention at baseline84.1 percentage of participants
Usual CarePercentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV)Human papillomavirus (HPV) : Vaccine intention at follow-up85.7 percentage of participants
Multi-Component InterventionPercentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV)Human papillomavirus (HPV) : Vaccine intention at baseline84.4 percentage of participants
Multi-Component InterventionPercentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV)Tetanus, diphtheria, acellular pertussis (Tdap) : Vaccine intention at baseline83.3 percentage of participants
Multi-Component InterventionPercentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV)Meningococcal conjugate vaccine (MCV) : Vaccine intention at follow-up91.6 percentage of participants
Multi-Component InterventionPercentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV)Tetanus, diphtheria, acellular pertussis (Tdap) : Vaccine intention at follow-up93.0 percentage of participants
Multi-Component InterventionPercentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV)Human papillomavirus (HPV) : Vaccine intention at follow-up87.3 percentage of participants
Multi-Component InterventionPercentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV)Meningococcal conjugate vaccine (MCV) : Vaccine intention at baseline80.5 percentage of participants
Comparison: Analysis for vaccine intention of Tdap95% CI: [1, 1.25]Regression, Logistic
Comparison: Analysis for vaccine intention of MCV95% CI: [1, 1.29]Regression, Logistic
Comparison: Analysis for vaccine intention of HPV95% CI: [0.96, 1.14]Regression, Logistic

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026